EU tackles medicine supply
EU Steering Group set up to provide strategic leadership


Colin Kerr
Published: Wednesday, March 25, 2020
An EU Executive Steering Group on shortages of medicines caused by major events has been set up to provide strategic leadership for urgent and coordinated action within the EU in case of a crisis caused by major events. The group has already discussed measures aimed at addressing the impact of the outbreak of COVID-19 on the supply of medicines in the EU.
The group will work on identifying and coordinating EU-wide actions to address disruptions of the supply of medicines, due to temporary lockdowns of manufacturing sites or travel restrictions or other factors.
The European Medicines Agency (EMA) and national medicines regulators are monitoring the potential impact of the COVID-19 outbreak on medicines and sharing information via the Single Point of Contact (SPOC) network on shortages. SPOCs are contact points at each human and veterinary medicines regulatory agency in the European Union/European Economic Area responsible for sharing information with other SPOCs and coordinating subsequent actions in relation to shortages and availability of authorised medicines.
For more information read here.
Tags: covid-19
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.